# Volitionrx Ltd: Form SCHEDULE 13D, filed Sep 4, 2026

- Company: [Volitionrx Ltd](/companies/vnrx.md) (CIK 93314)
- Form: SCHEDULE 13D
- Filed: 2026-09-04
- Accepted by EDGAR: Sep 4, 2026, 17:29 ET
- Period: not reported
- Accession: 0001493152-26-041611
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/93314/000149315226041611/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/93314/000149315226041611/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/93314/000149315226041611/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Sep 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-041611. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
